Indications and Purposes
| 1 Indications And Usage Zykadia ® Is Indicated For The Treatment Of Adult Patients With Metastatic Non-Small Cell Lung Cancer (Nsclc) Whose Tumors Are Anaplastic Lymphoma Kinase (Alk)-Positive As Detected By An Fda-Approved Test [See Dosage And Administration (2.1)] . Zykadia Is A Kinase Inhibitor Indicated For The Treatment Of Adults With Metastatic Non-Small Cell Lung Cancer (Nsclc) Whose Tumors Are Anaplastic Lymphoma Kinase (Alk)-Positive As Detected By An Fda-Approved Test. ( 1 , 2.1 ) |
All Formulated Excipients (0 Total)
None
Active Ingredients ( 1 Total)
| Name | Structure | ZINC ID(s) |
|---|---|---|
| 1. Ceritinib |
|
ZINC96272772 |